Jones Lang LaSalle Inc vs Eli Lilly And Co — how do they compare? Jones Lang LaSalle Inc trades at $325.29 (market cap $15.12B), while Eli Lilly And Co trades at $1,174.1 (market cap $1.02T). The key difference: Eli Lilly And Co is far larger — about 67.5× Jones Lang LaSalle Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while Jones Lang LaSalle Inc pays none. Which is the better fit depends on your goals.
| JLL | LLY | |
|---|---|---|
Market Cap | $15.12B | $1.02T |
Sector | Real Estate | Health |
52-Week High | $358.66 | $1.24K |
52-Week Low | $253.48 | $625.65 |
Enterprise Value | $18.66B | $1.06T |
Dividend Yield | — | 0.6% |
Trailing returns across standard periods
Latest headlines on both assets
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →